about
Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionSynthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusConsiderations for the rational design of a Chlamydia vaccineSublingual immunization of trivalent human papillomavirus DNA vaccine in baculovirus nanovector for protection against vaginal challenge.A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola InfectionDemonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG.Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.PEG modified liposomes containing CRX-601 adjuvant in combination with methylglycol chitosan enhance the murine sublingual immune response to influenza vaccinationEvaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.Mucosal vaccine delivery: Current state and a pediatric perspectiveAlternative administration routes and delivery technologies for polio vaccines.Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination.New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy.Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice.Developments in the formulation and delivery of spray dried vaccines.Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues.The Pharmacokinetics and Local Tolerability of a Novel Sublingual Formulation of Buprenorphine.In vitro evaluation of thio-poly acrylic acid for intraoral delivery.Bioavailability of House Dust Mite Allergens in Sublingual Allergy Tablets Is Highly Dependent on the Formulation.Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus.
P2860
Q27001897-0ED13A4E-01C0-4FD3-A4AD-B82AE89F39AEQ28067143-2C7FFF91-5314-4B9D-AB45-63D6FF06165AQ33601324-420EDF10-C251-4B81-817F-45A03B10AFE0Q35196568-E9454639-BC93-4D65-96B1-D45CE4596EAAQ35917501-A4FCC269-80C6-4E7A-A82A-E06399590F6FQ35959188-7E569F44-B8EF-43A1-B3C3-6E46E78B11DBQ36173746-79858A58-F271-409D-9597-B2EBEF7B836DQ36509826-D2E91D12-A8E2-41B7-84B5-A616A40B0F95Q37320147-36E3003D-8BF1-4F67-9A10-2E4F01C6BF72Q38401993-36285285-B850-4A9E-9B00-12E441FC45CEQ38727453-EBE2BF1F-A86A-4BC2-9083-50032F4644A3Q38748979-11794DFF-FCC7-4381-A6C3-2203DBE182ECQ38818697-62433E10-40F6-4DF0-B4B6-9371CDF73049Q38883770-656E4C4C-1479-413B-996F-02ADF645205DQ40412534-3C1CBE5E-E40B-458C-AD7F-5B26B6535287Q47106090-4A2F22EC-894F-4A16-9D48-C18F178C7660Q47316408-4343ED8C-8E8E-4A2B-8857-49228BC3C12AQ47556854-70B886F7-482B-4DC3-9439-EBF50F7FAA80Q47616247-F0171828-A8DE-47AA-AF73-73649AC4BFF8Q47741028-5F5AE4F7-2310-477A-BE03-9E8549FBB276Q52725104-1AF2BB34-E588-4665-B0A2-7F47EDAC8025Q53086117-827FCCFA-462C-45D2-81E3-4F187336F0C3
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Buccal and sublingual vaccine delivery.
@ast
Buccal and sublingual vaccine delivery.
@en
Buccal and sublingual vaccine delivery.
@nl
type
label
Buccal and sublingual vaccine delivery.
@ast
Buccal and sublingual vaccine delivery.
@en
Buccal and sublingual vaccine delivery.
@nl
prefLabel
Buccal and sublingual vaccine delivery.
@ast
Buccal and sublingual vaccine delivery.
@en
Buccal and sublingual vaccine delivery.
@nl
P2093
P1476
Buccal and sublingual vaccine delivery.
@en
P2093
Cecil Czerkinsky
Gideon Kersten
Heleen Kraan
Hilde Vrieling
Jean-Pierre Amorij
P304
P356
10.1016/J.JCONREL.2014.05.060
P407
P50
P577
2014-06-06T00:00:00Z